← Back to Methodology
RQS Scoring Log

BPC-157

Recovery & Performance· Animal Only· Scored May 2026· View compound profile →
23 /100
Weak Evidence
7 dimensions · 100 points total · Methodology by PeptideClear
Dimension Breakdown
DimensionScoring NotesScore
Study Design
Extensively studied in rats and mice — gastric ulcer, tendon, ligament, nerve, and muscle repair models. No published human RCTs. One old Croatian human safety case series (not a trial). Animal only.
5 / 25
Sample Size
No human efficacy participants. Rat studies typically 8-12 animals per group.
4 / 20
Replication
Animal findings replicated extensively in Sikiric group (Zagreb) and some independent labs. However, the majority of animal research comes from a single research group — limiting independent replication score.
5 / 20
Journal Impact Factor
Most publications in Current Pharmaceutical Design (IF ~2), Journal of Physiology-Paris (IF ~2-3), and lower-tier journals. Not published in high-impact journals.
4 / 15
Funding Independence
Croatian academic and government funding (University of Zagreb). Independent from industry, but narrow geographic base.
4 / 10
Population Diversity
Animal only. Not applicable.
0 / 5
Researcher h-Index
Sikiric group (Zagreb) — Predrag Sikiric has a substantial h-Index (~30+) in peptide/GI research and is the defining researcher for this compound.
1 / 5
Animal Only Note
This score reflects evidence in humans. Animal and in vitro evidence may be substantially stronger than the score suggests — this compound has not yet been studied in human trials.